アトピー性皮膚炎(Atopic Dermatitis)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Atopic Dermatitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis to Dermatology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Atopic Dermatitis 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Atopic Dermatitis Therapeutics Clinical Trials 33
Prominent Drugs 34
Latest Clinical Trials News on Atopic Dermatitis 35
Jun 08, 2015: Pfizer Announces 12 Presentations Including New Research Data on Tofacitinib for Chronic Plaque Psoriasis and Atopic Dermatitis at World Congress of Dermatology 35
May 05, 2015: Kineta Announces Promising Top-line Clinical Results for Dalazatide; Target Implicated in Broad Array of Autoimmune Diseases 36
May 04, 2015: Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 KINSHIP Trial of AQX-1125 in Atopic Dermatitis 37
Mar 16, 2015: AnGes Starts Phase III Clinical Trials of NF-kB Decoy Oligonucleotide Ointment Drug for Atopic Dermatitis in Japan 37
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Novartis AG 39
Clinical Trial Overview of Novartis AG 39
Astellas Pharma Inc. 44
Clinical Trial Overview of Astellas Pharma Inc. 44
Sanofi 46
Clinical Trial Overview of Sanofi 46
Regeneron Pharmaceuticals, Inc. 48
Clinical Trial Overview of Regeneron Pharmaceuticals, Inc. 48
GlaxoSmithKline Plc 50
Clinical Trial Overview of GlaxoSmithKline Plc 50
The LEO Foundation 51
Clinical Trial Overview of The LEO Foundation 51
Johnson & Johnson 52
Clinical Trial Overview of Johnson & Johnson 52
Bayer AG 53
Clinical Trial Overview of Bayer AG 53
Anacor Pharmaceuticals, Inc. 54
Clinical Trial Overview of Anacor Pharmaceuticals, Inc. 54
Sandoz International GmbH 55
Clinical Trial Overview of Sandoz International GmbH 55
Clinical Trial Overview of Top Institutes / Government 56
The National Institute of Allergy and Infectious Diseases 56
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 56
Wake Forest University 57
Clinical Trial Overview of Wake Forest University 57
Academic Medical Center 58
Clinical Trial Overview of Academic Medical Center 58
Dresden University of Technology 59
Clinical Trial Overview of Dresden University of Technology 59
National Center for Child Health and Development 60
Clinical Trial Overview of National Center for Child Health and Development 60
Oregon Health & Science University 61
Clinical Trial Overview of Oregon Health & Science University 61
University of California, San Diego 62
Clinical Trial Overview of University of California, San Diego 62
Yokohama City University 63
Clinical Trial Overview of Yokohama City University 63
Department of Health, UK 64
Clinical Trial Overview of Department of Health, UK 64
Hospices Civils de Lyon 65
Clinical Trial Overview of Hospices Civils de Lyon 65
Five Key Clinical Profiles 66
Appendix 86
Abbreviations 86
Definitions 86
Research Methodology 87
Secondary Research 87
About GlobalData 88
Contact Us 88
Disclaimer 88
Source 88